Entity monitoring profile
Wells Pharmacy Network Verification and Monitoring Profile
Federal 503B registration status for Wells Pharmacy Network, checked against the complete FDA register, with the open fields that remain.
A registration carrying the Wells name appears on FDA's outsourcing facility list, but the registered legal name differs from Wells Pharmacy Network and corporate identity has not been confirmed. This is recorded as a name match rather than a verified identity — treating them as the same entity without corporate records would be an inference this platform does not make. No inspection outcome, Form 483, warning letter, recall, or disciplinary record has been verified for this entity, so none is published.
Key findings
- Federal 503B registration: Name match on the 503B register; legal identity unconfirmed.
- Two registrations carry the Wells name. Whether either is the same legal entity as the consumer-facing Wells Pharmacy Network has not been confirmed against corporate records, so this is recorded as a name match rather than a veri
- Registration means FDA received the required filing — it is not approval and not a CGMP finding.
- No inspection outcome, Form 483, warning letter, recall or disciplinary record is verified for this entity.
- Checked against the complete FDA register of 96 outsourcing facility registrations.
| Entity name as published | Wells Pharmacy Network |
|---|---|
| Federal 503B registration | Conflicting Evidence Name match on the 503B register; legal identity unconfirmed |
| Registered site(s) on FDA list |
|
| Registry checked against | 96 registrations, FDA list, 2026-07-23 |
| Operating model | See registered sites above |
| State licence and number | Verification Pending |
| Nonresident licences | Verification Pending |
| FDA inspection history | Verification Pending |
| Form 483 observations | Verification Pending |
| Warning letters | Verification Pending |
| Most recent action status | Verification Pending |
| Recalls (current) | Verification Pending |
| Recalls (historical) | Verification Pending |
| State disciplinary records | Verification Pending |
| Accreditations | Verification Pending |
| Ownership | Verification Pending |
Federal registration status
Two registrations carry the Wells name. Whether either is the same legal entity as the consumer-facing Wells Pharmacy Network has not been confirmed against corporate records, so this is recorded as a name match rather than a verified identity.
Registration and inspections are facility specific. Facilities under common ownership and control are inspected individually. Before purchasing, FDA advises determining that the specific facility in which the drugs are compounded is an outsourcing facility with a satisfactory inspection. FDA
| Registered facility name | Location |
|---|---|
| Wells Pharma of Houston, LLC | Houston, TX |
| Wells Pharmacy, Inc. | Dyersburg, TN |
What this means
- The full federal register was checked and the result is stated with its date.
- Absence is reported as absence from a named list, not as a finding.
- The state board holds the licence record that would complete this profile.
What this does not mean
- That this entity is compliant, safe, or non-compliant — none is asserted.
- That federal registration constitutes approval or a CGMP finding.
- That absence from this list indicates any problem — it does not.
What can and cannot be established about Wells Pharmacy Network today?
Verification of a compounding entity runs across two separate systems that do not talk to each other. The federal system covers outsourcing facilities only: registration, CGMP inspection, Form 483 observations, warning letters and recalls. The state system covers licensure, scope of permitted compounding, and discipline — and it is the only system that covers 503A pharmacies at all.
For Wells Pharmacy Network, the federal side is settled at this snapshot: name match on the 503b register; legal identity unconfirmed. The state side is not, and that is where the remaining evidentiary weight sits.
| Question | System that answers it | Status for this entity |
|---|---|---|
| Is it federally registered as a 503B facility? | FDA outsourcing facility register | Conflicting Evidence |
| Is its state pharmacy licence current? | State board of pharmacy | Verification Pending |
| Is it permitted to compound sterile preparations? | State board permit class | Verification Pending |
| Has FDA inspected it, and what was found? | FDA inspection records | Verification Pending |
| Are there Form 483 observations? | FDA inspection records | Verification Pending |
| Is there an active warning letter? | FDA warning letter database | Verification Pending |
| Any current or historical recalls? | FDA enforcement reports | Verification Pending |
| Any state disciplinary action? | State board orders | Verification Pending |
Why 2 separate entries matter
Wells Pharmacy Network appears 2 times on the federal register because registration is per facility, not per company. Registration and inspections are facility specific. Facilities under common ownership and control are inspected individually. Before purchasing, FDA advises determining that the specific facility in which the drugs are compounded is an outsourcing facility with a satisfactory inspection. FDA
The practical consequence is that a finding at one site — an inspection outcome, a 483, a recall — describes that site and not the others. Reporting a company-level conclusion from a single-facility record is one of the most common errors in this sector, and this platform does not make it.
What a buyer should do with this record
This page settles one question and names the records that settle the rest. It is a starting point for verification, not a substitute for it.
If a programme names Wells Pharmacy Network as its dispensing pharmacy, the next step is the state board register — that confirms whether the licence is current today, which no snapshot can. Then, if a 503B claim is made, confirm it against the FDA register directly rather than accepting the claim.
What remains open for Wells Pharmacy Network
With Wells Pharmacy Network absent from the federal register, the entire evidentiary weight falls on state records. The board of pharmacy in its resident state holds the licence, the scope of permitted compounding, and any disciplinary history.
To determine whether a registered outsourcing facility has been the subject of a state enforcement action, FDA directs the public to check with the State Board of Pharmacy for the state in which the facility is located. FDA
The method used for each field, and why none of it can be inferred, is set out on the methodology page. Sector-level context on the gap between registration and inspection is on the monitoring hub.
- Checked against FDA's register of 96 registrations on 2026-07-23; FDA updates the list weekly.
- Self-reported registration information on FDA's list has not been verified by FDA.
- State licensure, inspection outcomes and enforcement records have not been checked for this entity.
- Sector statistics describe the 503B population, not this entity.
Sources checked for this entity — 5 sources
- FDA Registered Outsourcing Facilities listchecked 2026-07-23
- FDA — Information for Outsourcing Facilitieschecked 2026-07-23
- FDA — Q&A: Outsourcing Facility Registrationchecked 2026-07-23
- FDA — Registered Outsourcing Facilitieschecked 2026-07-23
- FDA — Aligning Federal and State Regulation of Compounderschecked 2026-07-23
Related records in this section
Section hub: Pharmacy profiles · Methodology · Status definitions · Right to respond
Frequently asked questions
Is Wells Pharmacy Network on the FDA 503B register?
A registration carrying the Wells name appears — Wells Pharma of Houston, LLC (Houston, TX), Wells Pharmacy, Inc. (Dyersburg, TN) — but the registered legal name differs and corporate identity has not been confirmed.
Why is this recorded as a name match rather than a confirmed registration?
Because treating a similar trading name as the same legal entity would be an inference. Corporate records would be needed to establish identity, and they have not been checked.
What would confirm whether Wells Pharmacy Network holds the registration?
State corporate filings or the entity's own confirmation, matched against the registered legal name on FDA's list.
Does the name match imply anything about Wells Pharmacy Network?
No. It is a data-matching state, not a finding of any kind.
Can Wells Pharmacy Network still compound semaglutide or tirzepatide?
Both shortages are resolved and FDA proposed on 30 April 2026 to exclude both from the 503B bulks list, restricting bulk compounding by outsourcing facilities. Narrow patient-specific 503A compounding may remain available. This page assesses no entity's compliance.
Does this page allege anything about Wells Pharmacy Network?
No. It reports federal register status with its source and date, and lists what remains unverified. No violation, finding, or concern is asserted.
Sources
- FDA Registered Outsourcing Facilities list
- FDA — Information for Outsourcing Facilities
- FDA — Q&A: Outsourcing Facility Registration
- FDA — Registered Outsourcing Facilities
- FDA — Aligning Federal and State Regulation of Compounders
Update history
| Date | Change |
|---|---|
| 2026-07-23 | Record published at current snapshot. |
Dates change only for substantive updates. Entities may submit a correction or response through the right-to-respond process.